Activity levels cut-offs | ||
---|---|---|
At baseline | At 6 months | |
Moderate activity threshold | ||
-ROC curve analysis | 5 | 5 |
AUC | 0.83 | 0.83 |
Sensitivity/specificity | 67.7%/80.0% | 70.3%/76.9% |
-Anchoring method | ||
75th percentile of the distribution in MDA group | 8 (6; 8) | 6 (5 ;7) |
High activity threshold | ||
-ROC curve | 14 | 14 |
AUC | 0.96 | 0.93 |
Sensitivity/specificity | 92.9.0%/83.3% | 91.8%/75.0% |
Anchoring method | ||
-In non-MDA group | ||
75th percentile of the distribution | 14 (13 ; 18) | 11 (9; 15) |
MCII (95% CI) | ||
In the whole cohort | −3 (−5 to −2) | |
Among patients with ESSDAI≥5 at baseline | −4 (−7 to −2) |
AUC, area under the curve; ClinESSDAI, Clinical ESSDAI (ie, without the biological domain); ESSDAI, EULAR Sjögren's Syndrome Disease Activity Index; EULAR, European League Against Rheumatism; MDA, minimal disease activity; ROC, receiver operating characteristic.